Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities. European Journal of Clincal Pharmacology 19:157-165.
Using drug research done during the late 1970s, Elina Hemminki, a Finnish health services researcher, showed that studies of new drugs submitted to licensing authorities were less likely to be published subsequently if they had looked for adverse effects.
